The global Spatial Omics Market is estimated to be valued at US$ 292.1 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
The spatial omics market involves analysis of biological samples at a cellular and tissue level to identify biological molecules and interactions in their original spatial context. Spatial information reveals insights into intercellular heterogeneity, cellular organization and physiology that are lost with traditional bulk assays. Technologies in this market such as spatial transcriptomics, proteomics and multi-omics allow researchers to interrogate the expression and localization of genes, proteins and other molecules with micrometer or nanometer resolution in situ. This comprehensive molecular mapping aids in understanding disease pathology, drug response and more. Advances in microfluidics, imaging platforms and data analysis are driving widespread adoption of spatial techniques across fields like oncology, immunology and neuroscience.
Market key trends:
One of the key trends in the spatial omics market is the integration of multiple omics domains into a single spatial method. Multi-omic platforms now enable profiling of the transcriptome, proteome or epigenome along with other layers of biological information from the same sample region. This provides a more holistic view of molecular pathways and cell states. Another notable trend is automation of spatial methods via incorporation of robotics and fluid handling. Increased automation is improving throughput, reproducibility and accessibility of spatial technologies. It is also enabling high-parameter studies such as spatial proteomics at single-cell resolution. These technical advancements will propel the spatial omics field towards routine implementation in research and clinical settings.
Threat of new entrants: Low/moderate threat of new entrants as there is high capital requirement to manufacture instruments and substantial R&D investment needed in developing omics technologies.
Bargaining power of buyers: Moderate bargaining power of buyers due to availability of alternative techniques and presence of large number of established players.
Bargaining power of suppliers: Low bargaining power of suppliers due to availability of substitute components.
Threat of new substitutes: Moderate threat of new substitutes as different omics technologies can be utilized for spatial analysis.
Competitive rivalry: High competitive rivalry among key players to gain major market share.
Global Spatial Omics Market Demand is expected to witness high growth, exhibiting CAGR of 9.4% over the forecast period 2023 to 2030, due to increasing adoption of spatial genomics technologies for disease diagnosis and drug discovery.
Regional analysis: North America dominates the global spatial omics market due to high R&D investments by government and private organizations in omics technologies. Asia Pacific exhibits high growth rate owing to increasing funding for omics research and growing population.
Key players: Key players operating in the spatial omics market are 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode. 10x Genomics holds major share due to its extensive spatial omics product portfolio.